[96a5a0]: / output / allTrials / logical / NCT02622620_logical.json

Download this file

225 lines (225 with data), 11.3 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
{
"info": {
"nct_id": "NCT02622620",
"official_title": "",
"inclusion_criteria": "* Among the patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma), who received concurrent chemoradiation (CCRT) with temozolomide, the patients show the measurable enhancing portion (1 cm in the long diameter according to the RANO criteria) in the immediate f/up MRI after CCRT.\nHealthy volunteers allowed",
"exclusion_criteria": "* Among the patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma), who received concurrent chemoradiation (CCRT) with temozolomide, the patients do not show the measurable enhancing portion (1 cm in the long diameter according to the RANO criteria) in the immediate f/up MRI after CCRT.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Among the patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma), who received concurrent chemoradiation (CCRT) with temozolomide, the patients show the measurable enhancing portion (1 cm in the long diameter according to the RANO criteria) in the immediate f/up MRI after CCRT.",
"criterions": [
{
"exact_snippets": "patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma)",
"criterion": "high-grade glioma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "received concurrent chemoradiation (CCRT) with temozolomide",
"criterion": "concurrent chemoradiation with temozolomide",
"requirement": {
"requirement_type": "treatment history",
"expected_value": true
}
},
{
"exact_snippets": "measurable enhancing portion (1 cm in the long diameter according to the RANO criteria)",
"criterion": "measurable enhancing portion",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "cm"
}
}
},
{
"exact_snippets": "immediate f/up MRI after CCRT",
"criterion": "immediate follow-up MRI after CCRT",
"requirement": {
"requirement_type": "timing",
"expected_value": "immediate after CCRT"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma)",
"criterion": "high-grade glioma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "received concurrent chemoradiation (CCRT) with temozolomide",
"criterion": "concurrent chemoradiation with temozolomide",
"requirement": {
"requirement_type": "treatment history",
"expected_value": true
}
}
]
},
{
"exact_snippets": "immediate f/up MRI after CCRT",
"criterion": "immediate follow-up MRI after CCRT",
"requirement": {
"requirement_type": "timing",
"expected_value": "immediate after CCRT"
}
}
]
},
{
"exact_snippets": "measurable enhancing portion (1 cm in the long diameter according to the RANO criteria)",
"criterion": "measurable enhancing portion",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "cm"
}
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Among the patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma), who received concurrent chemoradiation (CCRT) with temozolomide, the patients do not show the measurable enhancing portion (1 cm in the long diameter according to the RANO criteria) in the immediate f/up MRI after CCRT.",
"criterions": [
{
"exact_snippets": "patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma)",
"criterion": "high-grade glioma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "received concurrent chemoradiation (CCRT) with temozolomide",
"criterion": "concurrent chemoradiation with temozolomide",
"requirement": {
"requirement_type": "treatment history",
"expected_value": true
}
},
{
"exact_snippets": "do not show the measurable enhancing portion (1 cm in the long diameter according to the RANO criteria)",
"criterion": "measurable enhancing portion",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": "<",
"value": 1,
"unit": "cm"
}
}
},
{
"exact_snippets": "immediate f/up MRI after CCRT",
"criterion": "immediate follow-up MRI after CCRT",
"requirement": {
"requirement_type": "timing",
"expected_value": "immediate"
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": "patients with high-grade glioma (glioblastoma multiforme or anaplastic astrocytoma)",
"criterion": "high-grade glioma",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "received concurrent chemoradiation (CCRT) with temozolomide",
"criterion": "concurrent chemoradiation with temozolomide",
"requirement": {
"requirement_type": "treatment history",
"expected_value": true
}
}
]
},
"then_criteria": {
"and_criteria": [
{
"exact_snippets": "do not show the measurable enhancing portion (1 cm in the long diameter according to the RANO criteria)",
"criterion": "measurable enhancing portion",
"requirement": {
"requirement_type": "size",
"expected_value": {
"operator": "<",
"value": 1,
"unit": "cm"
}
}
},
{
"exact_snippets": "immediate f/up MRI after CCRT",
"criterion": "immediate follow-up MRI after CCRT",
"requirement": {
"requirement_type": "timing",
"expected_value": "immediate"
}
}
]
},
"else_criteria": null
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}